Elite Pharmaceuticals Inc /Nv/ financial data

Symbol
ELTP on OTC
Industry
Pharmaceutical Preparations
Location
165 Ludlow Avenue, Northvale, NJ
State of incorporation
NJ
Fiscal year end
March 31
Former names
ELITE PHARMACEUTICALS INC /DE/ (to 2/8/2012)
Latest financial report
10-Q - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 323 % +55.5%
Quick Ratio 112 % +29.4%
Debt-to-equity 75.6 % +38.5%
Return On Equity -36.1 % -187%
Return On Assets -20.5 % -177%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.07B shares +4.96%
Common Stock, Shares, Outstanding 1.07B shares +4.96%
Entity Public Float 95.1M USD +135%
Common Stock, Value, Issued 1.07M USD +4.96%
Weighted Average Number of Shares Outstanding, Basic 1.07B shares +5.27%
Weighted Average Number of Shares Outstanding, Diluted 1.07B shares +4.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 70M USD +47.9%
Cost of Revenue 39.1M USD +54.9%
Research and Development Expense 7.64M USD -1.28%
General and Administrative Expense 9.21M USD +55.2%
Operating Income (Loss) 12.2M USD +82.5%
Nonoperating Income (Expense) -29.5M USD -226%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.3M USD -626%
Income Tax Expense (Benefit) 239K USD
Net Income (Loss) Attributable to Parent -18M USD -216%
Earnings Per Share, Basic -0.01 USD/shares -200%
Earnings Per Share, Diluted -0.01 USD/shares -200%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.11M USD -9.27%
Accounts Receivable, after Allowance for Credit Loss, Current 18.5M USD +15.3%
Inventory, Net 20.2M USD +40.7%
Assets, Current 48M USD +29.3%
Deferred Income Tax Assets, Net 20.7M USD +2.25%
Property, Plant and Equipment, Net 9.86M USD -2.29%
Operating Lease, Right-of-Use Asset 2.11M USD +7947%
Assets 90.8M USD +21.5%
Accounts Payable, Current 5.84M USD +102%
Employee-related Liabilities, Current 206K USD
Accrued Liabilities, Current 3.72M USD -68.7%
Contract with Customer, Liability, Current 8.89K USD -33.3%
Liabilities, Current 14.7M USD -23.3%
Contract with Customer, Liability, Noncurrent 2.22K USD -85.7%
Operating Lease, Liability, Noncurrent 1.68M USD
Liabilities 54.3M USD +92%
Retained Earnings (Accumulated Deficit) -138M USD -15%
Stockholders' Equity Attributable to Parent 36.4M USD -21.5%
Liabilities and Equity 90.8M USD +21.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.14M USD
Net Cash Provided by (Used in) Financing Activities -175K USD -104%
Net Cash Provided by (Used in) Investing Activities -1.66M USD
Common Stock, Shares Authorized 1.45B shares 0%
Common Stock, Shares, Issued 1.07B shares +4.96%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.31M USD +4.72%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.74M USD +40%
Interest Paid, Excluding Capitalized Interest, Operating Activities 223K USD +86.7%
Deferred Tax Assets, Valuation Allowance 2.04M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.12 pure
Deferred Tax Assets, Gross 24.3M USD +7.46%
Operating Lease, Liability 2.13M USD +8037%
Depreciation 1.19M USD -8.85%
Payments to Acquire Property, Plant, and Equipment 779K USD
Property, Plant and Equipment, Gross 26.6M USD +3.62%
Operating Lease, Liability, Current 457K USD +1644%
Lessee, Operating Lease, Liability, to be Paid, Year Two 653K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 18.9K USD +27.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +66.7%
Deferred Income Tax Expense (Benefit) 18.2K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 455K USD +62424%
Lessee, Operating Lease, Liability, to be Paid, Year Three 667K USD
Deferred Tax Assets, Operating Loss Carryforwards 15.5M USD -11.8%
Current Income Tax Expense (Benefit) -19.8M USD -130%
Lessee, Operating Lease, Liability, to be Paid, Year Four 666K USD
Additional Paid in Capital 173M USD +4.82%
Depreciation, Depletion and Amortization 322K USD -1.88%
Deferred Tax Assets, Net of Valuation Allowance 24.3M USD +1018%
Share-based Payment Arrangement, Expense 228K USD +85.6%
Interest Expense 589K USD -47.1%